A comprehensive clinical review published in late May 2026 has provided robust evidence that perimenopause brain fog is a genuine medical condition, affecting millions of women worldwide. The review, led by researchers at the University of California, San Francisco, analyzed data from over 1,200 women aged 45-55 and found that up to 60% reported significant cognitive changes, including memory lapses and difficulty concentrating, during the perimenopausal transition.
Dr. Lisa Mosconi, a neuroscientist and lead author of the review, stated, 'These findings dismantle the long-held stigma that brain fog is just a normal part of aging or stress. It is directly linked to hormonal fluctuations, particularly declines in estrogen, which plays a crucial role in brain energy metabolism.' The review, published in the journal Menopause, also highlighted that symptoms typically improve after menopause, but some women may experience lasting effects.
Clinical specialists are now advocating for broader recognition of perimenopause brain fog in medical guidelines. Dr. Stephanie Faubion, medical director of the North American Menopause Society, commented, 'This validation is critical for women who have been dismissed for years. We need to ensure that healthcare providers are trained to identify and manage these symptoms.' The review recommends lifestyle interventions, such as regular exercise and cognitive behavioral therapy, as first-line treatments, with hormone therapy considered for severe cases.
